Literature DB >> 32275337

Financial barriers in a county genetics clinic: Problems and solutions.

Deanna J Erwin1, Christina LaMaire2, Alex Espana3, Tanya N Eble3, Shweta U Dhar3.   

Abstract

A genetic evaluation may lead to a clinical or molecular diagnosis, which helps clarify prognosis, tailor surveillance protocols based on risks associated with the genetic condition, and aid in assessment of risk to family members. However, individuals of low socioeconomic and/or minority status often have limited access to genetics services, which contributes to healthcare disparities (Journal of Community Genetics, 2018, 9, 233). Our county hospital system, dedicated to providing health care to the underserved, offers a unique opportunity to reduce healthcare inequalities in genetics. This retrospective chart review included 2,304 patients evaluated at an outpatient county hospital genetics clinic between January 1, 2013, and December 31, 2018, during which time genetic testing was recommended for most patients (58.5%) for a total of 1,429 recommended genetic tests. Most tests were obtained through non-hospital financial resources (56.5%), and loss to follow-up during the phlebotomy stage was the most common reason for tests not to be ordered (41.9%) and not to be completed (36.4%). The experience in our clinic suggests that identifying financial avenues, such as commercial laboratory financial assistance programs in addition to county hospital funds, can support obtaining genetic testing and allow healthcare providers to overcome financial barriers to genetic testing.
© 2020 National Society of Genetic Counselors.

Entities:  

Keywords:  access; county genetics clinic; financial barriers; genetic testing; underrepresented populations

Mesh:

Year:  2020        PMID: 32275337     DOI: 10.1002/jgc4.1279

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  4 in total

Review 1.  Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress.

Authors:  Juliet K Knowles; Ingo Helbig; Cameron S Metcalf; Laura S Lubbers; Lori L Isom; Scott Demarest; Ethan M Goldberg; Alfred L George; Holger Lerche; Sarah Weckhuysen; Vicky Whittemore; Samuel F Berkovic; Daniel H Lowenstein
Journal:  Epilepsia       Date:  2022-07-17       Impact factor: 6.740

2.  Socioeconomic Status and Interest in Genetic Testing in a US-Based Sample.

Authors:  E J Dusic; Deborah J Bowen; Robin Bennett; Kevin C Cain; Tesla Theoryn; Mariebeth Velasquez; Elizabeth Swisher; Jeannine M Brant; Brian Shirts; Catharine Wang
Journal:  Healthcare (Basel)       Date:  2022-05-10

3.  Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings.

Authors:  Grace A Lin; Julia R Trosman; Michael P Douglas; Christine B Weldon; Maren T Scheuner; Allison Kurian; Kathryn A Phillips
Journal:  J Genet Couns       Date:  2021-07-07       Impact factor: 2.537

4.  Hereditary cancer panel testing challenges and solutions for the latinx community: costs, access, and variants.

Authors:  Michael P Douglas; Grace A Lin; Julia R Trosman; Kathryn A Phillips
Journal:  J Community Genet       Date:  2021-11-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.